Skip to main content

Immunohistology in the Classification of Lung Cancer

  • Chapter
Lung Cancer: Basic and Clinical Aspects

Part of the book series: Cancer Treatment and Research ((CTAR,volume 28))

Abstract

Primary lung tumors constitute a wide spectrum of neoplasms which vary greatly in their biologic properties and clinical behaviour. By far the majority of lung cancers are carcinomas which by morphological criteria can be classified in the following major groups: squamous cell (epidermoid) carcinoma, small cell carcinoma, adenocarcinoma, large cell carcinoma, adenos-quamous carcinoma, carcinoid tumor and bronchial gland carcinomas [1]. This histopathological classification also forms the basis for the decisions concerning therapy and, because of the numerous correlations between the tumor type and the prognosis and the clinical behaviour of the tumor, the accuracy of the histopathological diagnosis has become ever more important.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Histological typing of lung tumours, 2nd edition. International histological classification of tumours, No. 8. Geneva, World Health Organization, 1981.

    Google Scholar 

  2. Bolen JW, Thorning D: Histogenetic classification of pulmonary carcinomas. Pathol. Annu. 17:77–100, 1982.

    PubMed  Google Scholar 

  3. Gould VE, Memoli VA, Dardi LE: Multidirectional differentiation in human epithelial cancers. J. Submicroscop. Cytol 13:97–115, 1981.

    Google Scholar 

  4. Sternberger LA: Immunocytochemistry. 2nd edition. New York. Wiley and Sons, 1979.

    Google Scholar 

  5. Weber K, Osborn M: Cytoskeleton: Definition, structure and gene regulation. Pathol Res Pract 175:128–145, 1982.

    PubMed  CAS  Google Scholar 

  6. Lazarides E: Intermediate filaments: A chemically heterogeneous developmentally regulated class of proteins. Ann Rev Biochem. 51:219–250, 1982.

    Article  PubMed  CAS  Google Scholar 

  7. Lehto V-P, Virtanen I, Kurki P: Intermediate filaments anchor nuclei in nuclear monolayers of cultured human fibroblasts. Nature 272:175–177, 1978.

    Article  PubMed  CAS  Google Scholar 

  8. Bennett GS, Fellini SA, Croop JM, Otto JJ, Bryan J, Holtzer H: Differences among 100 Å filament subunits from different cell types. Proc Natl Acad Sci USA 75:4364–4368, 1978.

    Article  PubMed  CAS  Google Scholar 

  9. Franke WW, Schmid E, Osborn M, Weber K: Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci USA 75:5034–5038, 1978.

    Article  PubMed  CAS  Google Scholar 

  10. Virtanen I, Lehto VP, Lehtonen E, Vartio T, Stenman S, Kurki P, Wager O, Small JV, Dahl D, Badley RA: Expression of intermediate filaments in cultured cells. J Cell Sci 50:45–63, 1981.

    PubMed  CAS  Google Scholar 

  11. Franke WW, Schmid E, Schiller DL, Winter S, Jarasch ED, Moll R, Denk H, Jackson BW, Illmensee K: Differentiation-related patterns of expression of intermediate-size filaments in tissues and cultured cells. Cold Spring Harbor Symp Qunat Biol 46:431–453, 1982.

    Google Scholar 

  12. Osborn M, Weber K: Tumor diagnosis by intermediate filaments typing: a novel tool for surgical pathology. Lab Invest 48:372–394, 1983.

    PubMed  CAS  Google Scholar 

  13. Miettinen M, Lehto V-P, Virtanen I: Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastruct Pathol 7:83–107, 1984.

    Article  PubMed  CAS  Google Scholar 

  14. Moll R, Franke WW, Schiller DL, Geiger B, Krepier R: The catalog of human cytokera-tins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11–24, 1982.

    Article  PubMed  CAS  Google Scholar 

  15. Franke WW, Schiller DL, Moll R, Winter S, Schmid E, Engelbrecht I, Denk H, Krepier R, Platzer B: Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol 153:933–959, 1981.

    Article  PubMed  CAS  Google Scholar 

  16. Blobel GA, Moll R, Franke WW, Vogt-Myokopf I: Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines. Virchows Arch (Cell Pathol) 45:407–429, 1984.

    Article  CAS  Google Scholar 

  17. Virtanen I, Miettinen M, Lehto V-P, Kariniemi A-L, Paasivuo R: Diagnostic application of monoclonal antibodies to intermediate filaments. Ann NY Acad Sci in press, 1985.

    Google Scholar 

  18. Gusterson B, Mitchell D, Warburton M, Sloane J: Immunohistochemical localization of keratin in human lung tumors. Virchows Arch A (Pathol Anat) 394:269–277, 1982.

    Article  CAS  Google Scholar 

  19. Bejui-Thivolet F, Viae J, Thivolet J, Faure M: Intracellular keratins in normal and pathological bronchial mucosa. Immunocytochemical studies on biopsies and cell suspensions. Virchows Arch A (Pathol Anat) 395:87–98, 1982.

    Article  CAS  Google Scholar 

  20. Schlegel R, Banks-Schlegel S, McLeod JA, Pinkus GS: Immunoperoxidase localization of keratin in human neoplasms. Am J Pathol 101:41–50, 1980.

    PubMed  CAS  Google Scholar 

  21. Gabbiani G, Kapanci Y, Barazzone P, Franke WW: Immunochemical identification of intermediate-sized filaments in human neoplastic cells: a diagnostic aid for the surgical pathologist. Am J Pathol 104:206–216, 1981.

    PubMed  CAS  Google Scholar 

  22. Sieinski W, Dorsett B, loachim HL: Identification of prekeratin by immunofluorescence staining in the differential diagnosis of tumors. Human Pathol 12:452–458, 1981.

    Article  CAS  Google Scholar 

  23. Lehto V-P, Stenman S, Miettinen M, Dahl D, Virtanen I: Expression of neural-type of intermediate filaments as a distinguishing feature between oat cell carcinoma and other lung cancers. Am J Pathol 110:113–118, 1983.

    PubMed  CAS  Google Scholar 

  24. Said JW, Nash G, Banks-Schlegel S, Sassoon AF, Murakami S, Shintaku IP: Keratin in human lung tumors. Patterns of localization of different molecular-weight keratin proteins. Am J Pathol 113:27–32, 1983.

    PubMed  CAS  Google Scholar 

  25. Saba SR, Espinoza CG, Richman AV, Azar HA: Carcinomas of the lung: An ultrastructural and immunocytochemical study. Am J Clin Pathol 80:6–13, 1983.

    PubMed  CAS  Google Scholar 

  26. Nagle RB, McDaniel KM, Clark VA, Payne CM: The use of antikeratin antibodies in the diagnosis of human neoplasms. Am J Clin Pathol 79:458–466, 1983.

    PubMed  CAS  Google Scholar 

  27. Said JW, Nash G, Tepper JG, Banks-Schlegel S: Keratin proteins and carcinoembryonic antigen in lung carcinoma: An immunoperoxidase study of fifty-four cases, with ultra-structural correlations. Hum Pathol 14:70–76, 1983.

    Article  PubMed  CAS  Google Scholar 

  28. Banks-Schlegel SP, McDowell EM, Wilson TS, Trump BF, Harris CC: Keratin proteins in human lung carcinomas. Combined use of morphology, keratin immunocytochemistry and keratin immunoprecipitation. Am J Pathol 114:273–286, 1984.

    PubMed  CAS  Google Scholar 

  29. Gatter KC, Abdulaziz Z, Beverley P, Corvalan JRF, Ford C, Lane EB, Mota M, Nash JRG, Pulford K, Stein H, Taylor-Papadimitrious J, Woodhouse C, Mason DY: Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol 35:1253–1267, 1982.

    Article  PubMed  CAS  Google Scholar 

  30. Espinoza CG, Azar HA: Immunohistochemical localization of keratin-type proteins in epithelial neoplasms. Correlation with electron microscopic findings. Am J Clin Pathol 78:500–507, 1982.

    PubMed  CAS  Google Scholar 

  31. Ramaekers F, Huysmans A, Mosker O, Kant A, Jap P, Herman C, Vooijs P: Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology. Lab Invest 49:353–361, 1983.

    PubMed  CAS  Google Scholar 

  32. Corson JM, Pinkus GS: Mesothelioma. Profile of keratin proteins and carcinoembryonic antigen. An immunoperoxidase study of 20 cases and comparison with pulmonary carcinomas. Am J Pathol 108:79–88, 1982.

    Google Scholar 

  33. Walts AE, Said JW, Banks-Schlegel S: Keratin and carcinoembryonic antigen in exfoliated mesothelial and malignant cells: An immunoperoxidase study. Am J Clin Pathol 80:671–675, 1983.

    PubMed  CAS  Google Scholar 

  34. Ramaekers F, Puts J, Moesker O, Kant A, Jap P, Vooijs P: Demonstration of keratin in human adenocarcinomas. Am J Pathol 111:213–223, 1983.

    PubMed  CAS  Google Scholar 

  35. Van Muijen GNP, Ruiter DJ, Ponec M, Huiskens-Van Dermay C, Warnaar SO: Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors. Am J Pathol 114:9–17, 1984.

    PubMed  Google Scholar 

  36. Kahn HJ, Huang S-N, Hanna WM, Baumal R, Phillips MJ: Immunohistochemical localization of epidermal and mallory body cytokeratin in undifferentiated epithelial tumors. Am J Clin Pathol 81:184–191, 1984.

    PubMed  CAS  Google Scholar 

  37. Lehto V-P, Miettinen M, Dahl D, Virtanen I: Bronchial carcinoid cells contain neural type of intermediate filaments. Cancer 54:624–628, 1984.

    Article  PubMed  CAS  Google Scholar 

  38. Sappino A-P, Ellison ML, Gusterson BA: Immunohistochemical localization of keratin in small cell carcinoma of the lung: correlation with response to combination chemotherapy. Eur J Cancer Clin Oncol 19:1365–1370, 1983.

    Article  PubMed  CAS  Google Scholar 

  39. Ramaekers F, Puts J, Kant A, Moesker C, Jap P, Vooijs P: Differential diagnosis of human carcinomas, sarcomas and their metastases using antibodies to intermediate-sized filaments. Eur J Cancer Clin Oncol 18:1251–1257, 1982.

    Article  PubMed  CAS  Google Scholar 

  40. Kahn HJ, Hanna W, Yeger H, Baumal H: Immunohistological localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy. Am J Pathol 109:206–214, 1982.

    PubMed  CAS  Google Scholar 

  41. Blobel GA, Gould VA, Moll R, Lee I, Huszar M, Geiger B, Franke WW: Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Lab Invest 52:39–51, 1985.

    PubMed  CAS  Google Scholar 

  42. Osborn M, Altmannsberger M, Debus E, Weber K: Conventional and monoclonal antibodies to intermediate filament proteins in human tumor diagnosis. In: Cancer Cell. 1. The transformed phenotype. (AJ Levine, GF Vandewoude, WC Topp, JD Watson, Eds.). Cold Spring Harbor, pp. 191–200, 1984.

    Google Scholar 

  43. Berger G, Berger F, Bejui F, Bouvier R, Rochet M, Feroldi J: Bronchial carcinoid with fibrillary inclusions related to cytokeratins: An immunohistochemical and ultrastructural study with subsequent investigation of 12 foregut apudomas. Histopathol 8:245–253, 1984.

    Article  CAS  Google Scholar 

  44. Holden J, Churg A: Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol 8:277–279, 1984.

    Article  PubMed  CAS  Google Scholar 

  45. Bejui-Thivolet F, Patricot LM, Vauzelle JL, Viae J: Keratins in malignant mesotheliomas and pleural adenocarcinomas: Comparative immunohistochemical analysis with polyclonal and monoclonal antibodies. Path Res Pract 179:67–73, 1984.

    PubMed  CAS  Google Scholar 

  46. Ramaekers F, Haag D, Jap P, Vooijs PG: Immunochemical demonstration of keratin and vimentin in cytologic aspirates. Acta Cytol 28:385–392, 1984.

    PubMed  CAS  Google Scholar 

  47. Ghosh AK, Spriggs AI, Taylor-Papadimitriou J, Mason DY: Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. J Clin Pathol 36:1154–1164, 1983.

    Article  PubMed  CAS  Google Scholar 

  48. Van Muijen GNP, Ruiter DJ, Van Leeuwen C, Prins FA, Rietsema K, Warnaar SO: Cytokeratin and neurofilament in lung carcinomas. Am J Pathol 116:363–369, 1984.

    PubMed  Google Scholar 

  49. Minna JD, Bunn PA Jr, Carney DN, Cohen MH, Cutitta F, Fossie CK, BE jr, Gazdar ÅF, Ihde DC, Johnston-Early A, Matthews MJ, Makuch R, Ole H, Rosen S, Krasnow S, Minna J: Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer. Bull. Cancer 69:83–93, 1982.

    PubMed  CAS  Google Scholar 

  50. Lukeman JM, Mackar B: Diagnosis of poorly differentiated carcinoma of the lung. In: Biology and management of lung cancer. FA Greco (Eds.). Martinus Nijhoff Publishers. Boston, 1983, pp. 87–108, 1983.

    Google Scholar 

  51. Bergh J, Nilsson K, Dahl D, Andersson L, Virtanen I, Lento V-P: Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation. Lab Invest 51:307–315, 1984.

    PubMed  CAS  Google Scholar 

  52. Gould VA, Linnoila RI, Memoli VA, Warren WH: Neuroendocrine cells and neuroendocrine neoplasms of the lung. Pathol Ann 18:287–330, 1983.

    Google Scholar 

  53. Kahn HJ, Garrido A, Huang SJ, Baumal R: Intermediate filaments and tumor diagnosis. Lab Invest 49:509, 1983.

    Google Scholar 

  54. Lehto V-P, Miettinen M, Virtanen I: A dual expression of cytokeratin and neurofilaments in bronchial carcinoid cells. Int J Cancer (in press), 1985.

    Google Scholar 

  55. Altmannsberger M, Osborn M, Droese M, Weber K, Schauer A: Diagnostic value of intermediate filament antibodies in clinical cytology. Klin Wochenschr 62:114–118, 1984.

    Article  PubMed  CAS  Google Scholar 

  56. Franke WW, Schmid E, Winter S, Osborn M, Weber K: Widespread occurrence of intermediate-sized filaments of the vimentin-type in cultured cells from diverse vertebrates. Exp Cell Res 123:25–46, 1979.

    Article  PubMed  CAS  Google Scholar 

  57. Miettinen M, Lehto V-P, Virtanen I: Neuroendocrine carcinoma of the skin (Merkel cell carcinoma): Ultrastructural and immunohistochemical demonstration of neurofilaments. Ultrastruct Pathol 4:219–225, 1983.

    Article  PubMed  CAS  Google Scholar 

  58. Miettinen M, Lehto V-P, Dahl D, Virtanen I: Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract. Lab. Invest (in press), 1985.

    Google Scholar 

  59. Wu YJ, Parker LM, Binder N, Beckett MA, Sinard JH, Griffits CT, Rheinwald JG: The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 31:693–705, 1982.

    Article  PubMed  CAS  Google Scholar 

  60. Gazdar AF. Carnev DN. Minna JD: The bioloey of non-small cell lung cancer. Seminars in Oncol 10:3–19, 1983.

    CAS  Google Scholar 

  61. Warren WH, Memoli VA, Gould VE: Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplams. I Carcinoids Ultrastruct Pathol 6:15–27, 1984.

    Article  CAS  Google Scholar 

  62. Yalow RS: Big ACTH and bronchogenic carcinoma. Ann Rev Med 30:241–248, 1979.

    Article  PubMed  CAS  Google Scholar 

  63. Kameya T, Shimosato Y, Kodama T, Tsumuraya M, Koide T, Yamaguchi K, Abe K: Peptide hormone production by adenocarcinomas of the lung: its morphologic basis and histogenetic considerations. Virchows Arch (Pathol ANat) 400:245–257, 1983.

    Article  CAS  Google Scholar 

  64. Bergh J: The biology of human lung cancer in vitro, with special reference to small cell carcinoma. Thesis. Uppsala Universitet, 1984.

    Google Scholar 

  65. Schmechel DE, Marangos PJ, Brightman MW: Neuron specific enolase is a marker for peripheral and central neuroendocrine cells. Nature 276:834–836, 1976.

    Article  Google Scholar 

  66. Sheppard MN, Corrin B, Bennett MA, Marangos PJ, Bloom SR, Polak JM: Immunohistochemical localization of neuron specific enolase (NSE) in small cell carcinomas and carcinoid tumours of the lung. Histopathol 8:171–181, 1984.

    Article  CAS  Google Scholar 

  67. Carney DN, Marangos PJ, Idhe DC, Bunn PA, Cohen MH, Minna JD, Gazdar AF: Serum neuron specific enolase: A marker for disease extent and response to therapy of smal-cell lung cancer. Lancet i: 583–585, 1982.

    Google Scholar 

  68. Bergh J, Esscher T, Steinholtz L, Nilsson K, PÃ¥hlman S: Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Submitted.

    Google Scholar 

  69. Tapia FJ, Barbosa AJA, Marnagos PJ, Polak JM, Bloom SR, Dermody C, Pearse AGE: Neuron-specific enolase is produced by neuroendocrine tumors. Lancet i:808–811, 1981.

    Google Scholar 

  70. Odelstad L, Påhlman S, Nilsson K, Larsson E, Läckgren G, Johansson K-E, Hjerten S, Grotte G: Neuron specific enolase in relation to differentiation in human neuroblastoma. Brain Res 224:69–82, 1981.

    Article  PubMed  CAS  Google Scholar 

  71. Odelstad L, Påhlman S, Läckgren G, Larsson E, Nielsson K: Neuron-specific enolase: A marker for differential diagnosis of neuroblastoma and Wilms’ tumor. J Ped Surg 17:381–388, 1982.

    Article  CAS  Google Scholar 

  72. Dranoff G, Bigner DD: A word of caution in the use of neuron-specific enolase expression in tumor diagnosis. Arch Pathol Lab Med 108:535, 1984.

    PubMed  CAS  Google Scholar 

  73. Vinores SA, Bonnin JM, Rubinstein LJ, Marangos PJ: Immunohistochemical demonstration of neuron-specific enonase in neoplasms of the CNS and other tissues. Arch Pathol Lab Med 108:536–540, 1984.

    PubMed  CAS  Google Scholar 

  74. Wharton J, Polak JM, Bloom SR et al.: Bombesin-like immunoreactivity in the lung. Nature 273:769–770, 1978.

    Article  PubMed  CAS  Google Scholar 

  75. Moodey TW, Pert CB, Gazdar AF, Carney DN, Minna JD: High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science 214:1246–1248, 1981.

    Article  Google Scholar 

  76. Erisman MD, Linnoila RI, Hernandez O, Di Augustine RP, Lazarus LH: Human lung small cell carcinoma contains bobmesin. Proc Natl Acad Sci USA 79:2379–2383, 1982.

    Article  PubMed  CAS  Google Scholar 

  77. Tamai S, Kameya T, Yamaguchi K, Yanai N, Abe K, Yanaihara N, Yamazaki H, Kageyama K: Peripheral lung carcinoid tumor producing predominantly gastrin-releasing peptide (GRP). Cancer 52:273–281, 1983.

    Article  PubMed  CAS  Google Scholar 

  78. Spindel ER, Chin WW, Price J, Rees LH, Besser JGM, Habener JF: Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci USA 81:5699–5703, 1984.

    Article  PubMed  CAS  Google Scholar 

  79. Tsutsumi Y, Yoshiyouki R, Watanabe K, Yanoihara N: Immunohistochemical studies on gastrin-releasing peptide adrenocorticotropic hormone-containing cells in the human lung. Lab Invest 48:623–675, 1983.

    PubMed  CAS  Google Scholar 

  80. Gould VE: The endocrine lung (Editorial). Lab Invest 48:507–509, 1983.

    PubMed  CAS  Google Scholar 

  81. Willey JC, Lechner JF, Harris CC: Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. Exp Cell Res 153:245–248, 1984.

    Article  PubMed  CAS  Google Scholar 

  82. Lloyd RV, Wilson BS: Specific endocrine tissue marker defined by a monoclonal antibody. Science 222:628–630, 1983.

    Article  PubMed  CAS  Google Scholar 

  83. Wilson BS, Lloy RV: Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 115:458–468, 1984.

    PubMed  CAS  Google Scholar 

  84. Sherwin SA, Minna JD, Gazdar AF, Todaro GJ: Expression of epidermal and nerve growth factor receptors and soft agar growth factor production by human lung cancer cells. Cancer Res 41:3538–3542, 1981.

    PubMed  CAS  Google Scholar 

  85. Cowley G, Smith JA, Gusterson B, Hendler F, Ozanne B: The amount of EGF-receptors is elevated on squamous cell carcinomas. In: Cancer cell 1. The transformed phenotype, Levine AJ, Vande Woude GF, Topp WC, Watson JD (eds.) Cold Spring Harbor 1984. pp. 5–10, 1984.

    Google Scholar 

  86. Simms E, Gazdar AF, Abrams PG et al.: Growth of human small cell (oat-cell) carcinoma of the lung in serum-free growth factor supplemented medium. Cancer Res 40:456–461, 1980.

    Google Scholar 

  87. Carney DN, Bunn PA, Gazdar AF et al.: Selective growth of small cell carcinoma of the lung obtained from patient biopsies in serum-free hormone-supplemented medium. Proc Natl Acad Sci USA 78:3185–3189, 1981.

    Article  PubMed  CAS  Google Scholar 

  88. Baratz JA, Mclntire KR, Princier GL, Kornight KR, Herberman R: Purification and characterization of a human lung tumor-associated antigen. J Natl Cancer Inst 61:1035–1046, 1978.

    Google Scholar 

  89. Bell CE, Seetharam S: Expression of endodermally derived and neural crest-derived antigens by human lung and colon tumors. Cancer 44:13–18, 1979.

    Article  PubMed  Google Scholar 

  90. Okabe T, Kaizu T, Fujisawa M, Watanabe J, Kojima K, Yamashita T, Takaku F: Monoclonal antibodies to surface antigens of small cell carcinoma of the lung. Cancer REs 44:5273–5278, 1984.

    PubMed  CAS  Google Scholar 

  91. Rosen ST, Mulshine JL, Cutitta F, Fedorko J, Carney DN, Gazdar AF, Minna JD: Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies. Cancer Res 44:2052–2061, 1984.

    PubMed  CAS  Google Scholar 

  92. Tong AW, Lee J, Stone MJ: Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by novel immunization approach. Cancer Res 44:4987–4992, 1984.

    PubMed  CAS  Google Scholar 

  93. Yam LT, Winder CF: Immunocytochemical diagnosis of oat-cell carcinoma in pleural effusion. Acta Cytol 28:425–429, 1984.

    PubMed  CAS  Google Scholar 

  94. Varki NM, Resifeld RA, Walker LE: Antigens associated with a human lung adenocarcinoma defined by monoconal antibodies. Cancer Res 44:681–687, 1984.

    PubMed  CAS  Google Scholar 

  95. Mulshine JL, Cuttitta F, Bibro M, Fedorko J, Fargion S, Little C, Carney DN, Gazdar AF, Minna JD: Monoclonal antibodies distinguish non-small cell from small cell lung cancer. J. Immunol. 131:467–502, 1983.

    Google Scholar 

  96. Bosslet K, Kurrle R, Ax W, Sedlacec HH: Monoclonal murine antibodies with specificity for tissue culture lines jof human squamous-cell carcinoma of the lung. Cancer Det Prevent 6:181–184, 1983.

    CAS  Google Scholar 

  97. Goodwin G, Shaper JH, Abeloff MD, Mendelsohn G, Baylin SB: Analysis of cell surface proteins delineates a differentiation pathway linking endocrine and nonendocrine human lung cancers. Proc. Natl Acad Sci USA 80:3807–3811, 1983.

    Article  CAS  Google Scholar 

  98. Bergh J, Nilsson K, Cate CC, Pettengill OS, Sorenson GD: Cell surface glycoprotein patterns of cell lines derived from human small cell carcinoma of the lung. Acta Path Microbiol Immunol Scand Sect A 91:9–15, 1983.

    CAS  Google Scholar 

  99. Green H: Terminal differentiation of cultured human epidermal cells. Cell 11:405–412, 1977.

    Article  PubMed  CAS  Google Scholar 

  100. Bansk-Schlegel S, Green H: Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia. J. Cell BIol 90:732–743, 1981.

    Article  Google Scholar 

  101. Said JW, Nash G, Sassoon AF, Shintaku IP, Banks-Schlegel S: Involucrin in lung tumors. A specific marker for squamous differentiation. Lab Invest 49:563–568, 1983.

    PubMed  CAS  Google Scholar 

  102. Bishop JM: Cellular oncogenes and retroviruses. Ann Rev Biochem 52:301–354, 1983.

    Article  PubMed  CAS  Google Scholar 

  103. Weinberg RA: Oncogenes of spontaneous and chemically induced tumors. Adv Cancer Res 36:149–162, 1982.

    Article  PubMed  CAS  Google Scholar 

  104. Slamon DJ, de Kernion JB, Verma IM, Cline MJ: Expression of cellular oncogenes in human malignancies. 224:256–262, 1984.

    CAS  Google Scholar 

  105. Santos E, Martin-Zanca D, Reddy EP, Pierotti MA, Delia Porta G, Barbacid M: Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science 223:661–664, 1984.

    Article  PubMed  CAS  Google Scholar 

  106. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD: Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306:194–196, 1983.

    Article  PubMed  CAS  Google Scholar 

  107. Saksela K, Bergh J, Lehto V-P, Nilsson K, Alitalo K: Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Cancer Res in press, 1985.

    Google Scholar 

  108. Griffin CA, Baylin SB: Expression of the c-myc oncogene in human small cell lung carcinoma. Cancer Res 45:272–275, 1985.

    PubMed  CAS  Google Scholar 

  109. Hand PH, Thor A, Wunderlich D, Muraro R, Caruso A, Schlom J: Monoclonal antibodies of pre-determined specificity detect activated ras gene expression in human mammary and colon carcinomas. Proc Natl Acad Sci U.S.A. 81:5227–5231, 1984.

    Article  PubMed  CAS  Google Scholar 

  110. Burtin P: Membrane antigens of the colonic tumors. Cancer 34 [829–834, 1974.

    Article  PubMed  CAS  Google Scholar 

  111. Sun NCJ, Edgington TD, Carpenter CL, McAffee W, Terry R, Bateman J: Immunohistochemical localization of carcinoembryonic antigen (LEA), CEA-S, and nonspecific cross-reacting antigen (NCA) in carcinomas of lung. Cancer 52:1632–1641, 1983.

    Article  PubMed  CAS  Google Scholar 

  112. Wachner R, Wittekind C, von Kleist S: Localization of CEA, β-HCG, SP1, and keratin in the tissue of lung carcinomas. An immunohistochemical study. Virchows Arch (Pathol Anat) 402:415–423, 1984.

    Article  CAS  Google Scholar 

  113. Manning JT, Harlan J, Spjut J, Tschen JA: Bronchioalveolar carcinoma: the significance of two histopathologic types. Cancer 54:525–534, 1984.

    Article  PubMed  Google Scholar 

  114. Singh G, Katyal SL, Torikata K: Carcinoma of type II pneumocytes: immunodiagnosis of a subtype of ‘bronchioalveolar carcinomas’. Am J Pathol 102:195–208, 1981.

    PubMed  CAS  Google Scholar 

  115. Odell WD, Wolfsen AF, Yoshimoto Y et al.: Extopic peptide synthesis: A universal concomitant of neoplasia. Trans. Assoc Am Physicians 40:204–225.

    Google Scholar 

  116. Bader H, Altmannsberger M, Osborn M: Typing of intermediate filaments in malignant fibrous pleural tumors. J Cancer Res Clin Oncol 107:42–47, 1984.

    Article  PubMed  CAS  Google Scholar 

  117. Sidhu GS: The ultrastructure of malignant epithelial neoplasms of the lung. Pathol Annu 17:135–166, 1982.

    Google Scholar 

  118. Matthews J: Influence of clearing agent on immunohistochemical staining of paraffin-embedded tissue. J Clin Pathol 34: 103–105, 1981.

    Article  PubMed  CAS  Google Scholar 

  119. Taylor CR: Monoclonal antibodies and ‘routine’ paraffin sections. Arch Path Lab Med 109:114–116, 1985.

    Google Scholar 

  120. Pinkus GS: Diagnostic immunohistochemistry of paraffin-embedded tissues. Human Pathol 13:411–415, 1982.

    Article  CAS  Google Scholar 

  121. Kaku T, Ekern JK, Lindayen C, Bailey DJ, van Norstrand AWP, Farber E: Comparison of formalin- and acetone-fixation for immunohistochemical detection of carcinoembryonic antigen (CEA) and keratin. Am J Clin Pathol 80:808–816, 1983.

    Google Scholar 

  122. Altmannsberger, M, Osborn M, Schauer A, Weber K: Antibodies to different intermediate filament proteins. Cell type-specific markers on paraffin-embedded human tissues. Lab Invest 45:427–434, 1981.

    PubMed  CAS  Google Scholar 

  123. Stein H, Gatter KC, Hermet A, Mason DY: Freeze-dried paraffin-embedded human tissue for antigen labelling with monoclonal antibodies. The Lancet, July 14:71–73, 1984.

    Article  Google Scholar 

  124. Nagle RB, Clark VA, McDaniel KM, Davis JR: Immunohistochemical demonstration of keratins in human ovarian neoplasms. A comparison of methods. J. Histochem Cytochem 31:1010–1014, 1983.

    Article  PubMed  CAS  Google Scholar 

  125. Brozman M: Immunohistochemical analysis of formaldehyde- and trypsin- or pepsin-treated material. Acta Histochem (JENA) 63:251–260, 1978.

    CAS  Google Scholar 

  126. Huang S-N, Minassian H, More JD: Application of immunofluorescent staining on paraffin sections improved by trypsin digestion. Lab Invest 35:383–390, 1976.

    PubMed  CAS  Google Scholar 

  127. Nash G: The diagnosis of lung cancer in the 80’s: Will routine light microscopy suffice. Human Pathol 14:1021–1023, 1983.

    Article  CAS  Google Scholar 

  128. Sobin LH: The histologic classification of lung tumors: The need for a double standard. Human Pathol. 14:1020–1021, 1983.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Lehto, VP., Bergh, J., Virtanen, I. (1986). Immunohistology in the Classification of Lung Cancer. In: Hansen, H.H. (eds) Lung Cancer: Basic and Clinical Aspects. Cancer Treatment and Research, vol 28. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2295-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2295-5_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9414-6

  • Online ISBN: 978-1-4613-2295-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics